According to DelveInsight's analysis, the chronic induced urticaria (CIndU) pipeline consists of at least four leading companies actively developing four or more therapeutics to treat chronic induced urticaria. Overview of Chronic Induced Urticaria Chronic induced urticaria (CIndU) is a subtype of chronic urticaria that is triggered by specific physical or environmental factors such as...

    Pipeline insights for chronic spontaneous urticaria, DelveInsight According to DelveInsight analysis, the chronic spontaneous urticaria (CSU) pipeline consists of more than 20 leading companies actively developing more than 20 treatments for CSU. Overview of Chronic Spontaneous Urticaria: Urticaria, commonly known as hives, wheals, or nettle rash, is characterized by itchy, red,...

Key Players in the Chronic Urticaria MarketMajor pharmaceutical companies active in the chronic urticaria field include Sanofi-Aventis, Merck, UCB, Regeneron, Roche, Principia Biopharma, Novartis, AstraZeneca and Kyowa Kirin. Overview of the chronic urticaria treatment market (Albany, USA)- DelveInsight's "Chronic Urticaria – Market Insights, Epidemiology, and Market Forecast –...